- cafead   Jan 04, 2021 at 11:12: PM
via After guiding Myovant to a successful FDA approval and inking a $4.2 billion deal with pharma giant Pfizer, Chief Executive Officer (CEO) Lynn Seely is bowing out to make room for the next chief, David Marek.
article source
article source